SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-20-005507
Filing Date
2020-05-26
Accepted
2020-05-26 21:42:06
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 39106
2 GRAPHIC g933871g91e50.jpg GRAPHIC 7746
3 GRAPHIC g933871new11.jpg GRAPHIC 16288
4 GRAPHIC g933871new12.jpg GRAPHIC 6197
  Complete submission text file 0000950123-20-005507.txt   81767
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations